Literature DB >> 14966918

Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration.

Chen-Xia He1, Ding Shi, Wen-Jun Wu, You-Fa Ding, Deng-Min Feng, Bin Lu, Hao-Ming Chen, Ji-Hua Yao, Qi Shen, Da-Ru Lu, Jing-Lun Xue.   

Abstract

AIM: Transfer and expression of insulin gene in vivo are an alternative strategy to improve glycemic control in type 1 diabetes. Hydrodynamics-based procedure has been proved to be very efficient to transfer naked DNA to mouse livers. The basal hepatic insulin production mediated by this rapid tail vein injection was studied to determine its effect on the resumption of glycemic control in type 1 diabetic mice.
METHODS: Engineered insulin cDNA was inserted into plasmid vectors under a CMV promoter, and transferred into STZ induced diabetic mice by hydrodynamic procedure. Glucose levels, body weight of treated mice, insulin levels, immunohistology of the liver, and quantity of insulin mRNA in the liver were assayed to identify the improvement of hyperglycemic complication after plasmid administration. Sleeping Beauty, a transposon system, was also used to prolong the insulin expression in the liver.
RESULTS: After plasmid administration, Plasma insulin was significantly increased in the diabetic mice and the livers were insulin-positive by immunostaining. At the same time the hyperglycemic complication was improved. The blood glucose levels of mice were reduced to normal. Glucose tolerance of the treated diabetic mice was improved. Body weight loss was also ameliorated. The rapid tail vein injection did not cause any fatal result.
CONCLUSION: Our results suggested that insulin gene could be efficiently transferred into the livers of diabetic mice via rapid tail vein injection and it resulted in high level of insulin expression. The basal hepatic insulin production mediated by hydrodynamics-based administration improved the glycemic control in type 1 diabetes dramatically and ameliorated diabetic syndromes. Hydrodynamics-based administration offers a simple and efficient way in the study of gene therapy for type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966918      PMCID: PMC4716981          DOI: 10.3748/wjg.v10.i4.567

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo.

Authors:  D Yin; J G Tang
Journal:  FEBS Lett       Date:  2001-04-20       Impact factor: 4.124

2.  Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells.

Authors:  Z Ivics; P B Hackett; R H Plasterk; Z Izsvák
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

3.  Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.

Authors:  L Qin; Y Ding; D R Pahud; E Chang; M J Imperiale; J S Bromberg
Journal:  Hum Gene Ther       Date:  1997-11-20       Impact factor: 5.695

4.  Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

Authors:  S R Yant; L Meuse; W Chiu; Z Ivics; Z Izsvak; M A Kay
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

5.  Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats.

Authors:  P Muzzin; R C Eisensmith; K C Copeland; S L Woo
Journal:  Mol Endocrinol       Date:  1997-06

6.  Site-specific genomic integration produces therapeutic Factor IX levels in mice.

Authors:  Eric C Olivares; Roger P Hollis; Thomas W Chalberg; Leonard Meuse; Mark A Kay; Michele P Calos
Journal:  Nat Biotechnol       Date:  2002-10-15       Impact factor: 54.908

7.  Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice.

Authors:  A Sugiyama; S Hattori; S Tanaka; F Isoda; S Kleopoulos; M Rosenfeld; M Kaplitt; H Sekihara; C Mobbs
Journal:  Horm Metab Res       Date:  1997-12       Impact factor: 2.936

8.  Naked DNA delivered intraportally expresses efficiently in hepatocytes.

Authors:  V Budker; G Zhang; S Knechtle; J A Wolff
Journal:  Gene Ther       Date:  1996-07       Impact factor: 5.250

9.  Gene therapy for diabetes mellitus in rats by hepatic expression of insulin.

Authors:  T M Kolodka; M Finegold; L Moss; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

10.  Prevention of diabetes in the NOD mouse by intra-muscular injection of recombinant adeno-associated virus containing the preproinsulin II gene.

Authors:  R M Jindal; M Karanam; R Shah
Journal:  Int J Exp Diabetes Res       Date:  2001
View more
  14 in total

1.  High-resolution genome-wide mapping of transposon integration in mammals.

Authors:  Stephen R Yant; Xiaolin Wu; Yong Huang; Brian Garrison; Shawn M Burgess; Mark A Kay
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 2.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

Review 3.  Hydrodynamic gene delivery and its applications in pharmaceutical research.

Authors:  Barbara Bonamassa; Li Hai; Dexi Liu
Journal:  Pharm Res       Date:  2010-12-30       Impact factor: 4.200

4.  In vivo gene delivery by cationic tetraamino fullerene.

Authors:  Rui Maeda-Mamiya; Eisei Noiri; Hiroyuki Isobe; Waka Nakanishi; Koji Okamoto; Kent Doi; Takeshi Sugaya; Tetsuro Izumi; Tatsuya Homma; Eiichi Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

5.  In vivo inhibition of focal adhesion kinase causes insulin resistance.

Authors:  Bharti Bisht; K Srinivasan; Chinmoy S Dey
Journal:  J Physiol       Date:  2008-06-26       Impact factor: 5.182

6.  Gene expression in lung and liver after intravenous infusion of polyethylenimine complexes of Sleeping Beauty transposons.

Authors:  Kelly M Podetz-Pedersen; Jason B Bell; Terry W J Steele; Andrew Wilber; W Thomas Shier; Lalitha R Belur; R Scott McIvor; Perry B Hackett
Journal:  Hum Gene Ther       Date:  2010-02       Impact factor: 5.695

7.  Role of recombinant plasmid pEGFP-N1-IGF-1 transfection in alleviating osteoporosis in ovariectomized rats.

Authors:  Hai Chun Liu; Hua Zhao; Jian Chen; Wen Liang Wu; Hong Liang Wang; Gang Jun Jiao; Yun Zhen Chen
Journal:  J Mol Histol       Date:  2013-03-19       Impact factor: 2.611

Review 8.  A transposon and transposase system for human application.

Authors:  Perry B Hackett; David A Largaespada; Laurence J N Cooper
Journal:  Mol Ther       Date:  2010-01-26       Impact factor: 11.454

9.  Retargeting transposon insertions by the adeno-associated virus Rep protein.

Authors:  Ismahen Ammar; Andreas Gogol-Döring; Csaba Miskey; Wei Chen; Toni Cathomen; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  Nucleic Acids Res       Date:  2012-04-19       Impact factor: 16.971

10.  Nonviral in vivo gene transfer in the mucopolysaccharidosis I murine model.

Authors:  M Camassola; L M Braga; A Delgado-Cañedo; T P Dalberto; U Matte; M Burin; R Giugliani; N B Nardi
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.